This course has expired. View available courses.
Endocrinology
New, Effective Hyperkalemia Management and Enabling Optimal RAASi Therapy
Hyperkalemia is a frequent and dangerous clinical challenge in the medical management of patients on renin-angiotensin-aldosterone system inhibitor (RAASi) therapy. RAASi therapy provides many health benefits to patients with renal dysfunction and heart disease. Patients on RAASi therapy experience hyperkalemia and often need dose adjustments or discontinuation to address the hyperkalemia. This program will outline the benefit of using newer, safer binding resins in addition to standard best practices, to support effective treatment of clinically significant hyperkalemia
This program has received an educational grant from Vifor Pharma
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-02-28
Hyperkalemia is a frequent and dangerous clinical challenge in the medical management of patients on renin-angiotensin-aldosterone system inhibitor (RAASi) therapy. RAASi therapy provides many health benefits to patients with renal dysfunction and heart disease. Patients on RAASi therapy experience hyperkalemia and often need dose adjustments or discontinuation to address the hyperkalemia. This program will outline the benefit of using newer, safer binding resins in addition to standard best practices, to support effective treatment of clinically significant hyperkalemia
This material has been developed with educational support from CSL Vifor.
Faculty
Amal Najrani, MD
Javid Butler, MD, MPH, MBA
David Strain, MBChB, MD, FRCP
Learning objectives
After completion of this program, participants will be better able to:
- Outline the causes of hyperkalemia, the burden of disease, and its impact of morbidity and mortality
- Describe the role of new potassium-binder therapy versus traditional therapy in the management of hyperkalemia
- Review the considerations for making treatment choices, including the benefits of maintaining optimal RAASi therapy and dosing
- Identify specific at-risk patient types and apply the latest recommendations for treatment and management of hyperkalemia